gliogrey TEMOZOLOMIDE

Introduction to gliogrey

Gliogrey is a medication available in tablet form, primarily used to treat certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Gliogrey works by targeting cancer cells in the brain.

Composition of gliogrey

Gliogrey contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage and preventing them from multiplying.

Uses of gliogrey

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of gliogrey

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: low blood cell counts, increased risk of infection

Precautions of gliogrey

Patients should be aware that gliogrey can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Those with severe bone marrow suppression should avoid using this medication.

How to Take gliogrey

Gliogrey is taken orally, usually as a tablet. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of gliogrey

Gliogrey, containing the active ingredient Temozolomide, is a therapeutic agent used in the treatment of aggressive brain tumors. It is manufactured for oral administration and belongs to the class of alkylating agents. Key highlights include its effectiveness in treating glioblastoma multiforme and anaplastic astrocytoma, with common side effects such as nausea and fatigue. Always consult your healthcare provider for personalized advice on using gliogrey.